In vivo, animal models inoculated with E0771 breast cancer cell line, a luminal-B like model, further confirms EGFG’s inhibition of angiogenesis and breast cancer progression due to lesser levels of VEGF and HIF-1α, along with NFκB [52]. Here, NFKB1 is linked to breast carcinoma.